Its co-localization with the transcription factor β-catenin is oriented along the Wnt pathway, which results in decreased transcription of the target genes cyclinD1 and c-myc, thereby inhibiting tumor growth in HCC. Here, MYC is linked to hepatocellular carcinoma.